Balance Sheet

Assets

+19%

+30%

10Y

Currency: USD

	Dec-2002	Dec-2003	Dec-2004	Dec-2005	Dec-2006	Dec-2007	Dec-2008	Dec-2009	Dec-2010	Dec-2011	Dec-2012	Dec-2013	Dec-2014	Dec-2015	Dec-2016	Dec-2017	Dec-2018	Dec-2019	Dec-2020	Dec-2021	Dec-2022	Dec-2023	Dec-2024	Dec-2025
Assets
Cash & Cash Equivalents	34	121	13	38	89	228	223	167	88	46	181	569	876	397	408	598	494	437	649	587	725	499	613	896
Cash Equivalents	34	121	13	38	89	228	223	167	88	46	181	569	876	397	408	598	494	437	649	587	725	499	613	896
Short-Term Investments	45	89	38	11	201	359	337	134	186	149	267	216	70	196	381	798	590	316	416	427	567	345	195	249
Total Receivables	0	0	4	6	15	22	89	81	94	105	109	118	154	179	215	261	343	377	448	373	461	634	661	908
Accounts Receivables	0	0	4	6	15	17	84	74	87	105	109	118	145	165	215	261	343	377	448	373	461	634	661	908
Other Receivables	0	0	0	0	0	5	5	7	7	0	0	0	10	14	0	0	0	0	0	0	0	0	0	0
Inventory	0	0	2	11	25	32	73	79	110	130	129	163	200	272	355	476	531	680	699	777	894	1 107	1 233	1 299
Other Current Assets	2	3	28	3	4	3	15	8	27	40	58	72	99	46	62	74	98	131	130	110	105	141	202	186
Total Current Assets	81	213	85	69	334	644	738	468	504	470	743	1 137	1 398	1 090	1 422	2 207	2 056	1 942	2 342	2 274	2 752	2 956	3 232	3 953
PP&E Net	28	25	43	37	56	77	125	199	222	269	285	319	524	704	799	897	949	1 070	1 090	1 082	1 114	1 112	1 077	992
PP&E Gross	28	25	43	37	56	77	125	199	222	269	285	319	524	704	799	897	949	1 070	1 090	1 082	1 114	1 112	1 077	992
Accumulated Depreciation	21	30	38	44	27	35	46	62	85	116	149	185	229	279	343	407	473	549	636	721	802	867	892	1 074
Intangible Assets	0	0	17	15	12	10	8	41	104	180	163	163	157	684	554	518	492	457	417	389	339	295	255	320
Goodwill	0	0	45	21	21	21	21	24	53	52	52	54	54	197	197	197	197	197	196	196	196	196	196	196
Long-Term Investments	0	12	23	32	32	45	3	170	129	95	117	269	98	426	573	386	236	412	286	508	334	622	528	492
Other Long-Term Assets	1	6	21	21	9	18	13	15	250	240	209	301	246	629	480	429	498	612	1 517	1 554	1 641	1 660	1 700	1 640
Other Assets	0	0	45	21	21	21	21	24	53	52	52	54	54	197	197	197	197	197	196	196	196	196	196	196
Total Assets	111 N/A	256 +132%	233 -9%	195 -16%	463 +137%	815 +76%	907 +11%	917 +1%	1 263 +38%	1 306 +3%	1 568 +20%	2 244 +43%	2 475 +10%	3 729 +51%	4 024 +8%	4 633 +15%	4 427 -4%	4 690 +6%	5 848 +25%	6 003 +3%	6 375 +6%	6 842 +7%	6 989 +2%	7 594 +9%
Liabilities
Accounts Payable	0	0	1	1	2	1	1	8	5	0	24	37	144	186	199	162	208	241	191	193	231	316	235	313
Accrued Liabilities	4	10	24	18	26	47	57	62	68	76	117	137	82	198	159	202	213	288	266	277	318	323	351	407
Short-Term Debt	0	0	0	0	0	0	0	0	0	0	23	0	0	0	0	0	0	0	0	0	0	0	0	0
Current Portion of Long-Term Debt	3	3	43	11	7	6	71	0	0	0	0	0	0	0	23	361	0	365	3	2	2	494	0	0
Other Current Liabilities	0	0	2	10	11	7	1	9	11	19	6	10	9	61	59	92	102	39	32	68	38	45	20	40
Total Current Liabilities	7	13	70	40	46	62	130	78	84	94	170	183	236	446	439	817	523	933	493	540	589	1 177	607	759
Long-Term Debt	5	126	228	213	293	564	497	497	378	348	325	656	643	662	661	814	830	493	1 079	1 081	1 083	593	596	598
Deferred Income Tax	0	0	0	0	0	0	0	3	37	37	0	0	0	144	0	0	0	0	0	0	0	0	0	0
Other Liabilities	0	0	3	20	7	2	3	17	48	53	57	64	69	77	157	194	106	142	170	112	100	120	128	150
Total Liabilities	12 N/A	139 +1 045%	301 +117%	273 -9%	346 +27%	628 +82%	630 +0%	595 -6%	545 -8%	533 -2%	553 +4%	903 +63%	948 +5%	1 329 +40%	1 257 -5%	1 825 +45%	1 459 -20%	1 568 +7%	1 742 +11%	1 733 -1%	1 772 +2%	1 890 +7%	1 331 -30%	1 507 +13%
Equity
Common Stock	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Retained Earnings	226	301	489	563	592	607	577	577	371	425	539	716	850	1 022	1 521	1 638	1 694	1 721	862	926	789	622	195	154
Additional Paid In Capital	324	419	421	486	709	795	853	900	1 090	1 197	1 562	2 059	2 360	3 415	4 288	4 483	4 670	4 833	4 993	5 192	5 405	5 612	5 802	5 957
Unrealized Security Profit/Loss	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	3	2	4	4	1	12	1	2	4
Other Equity	0	0	0	0	0	0	0	1	2	1	7	2	18	7	2	35	6	7	30	6	1	40	49	28
Total Equity	99 N/A	118 +20%	68 N/A	78 -14%	118 N/A	188 +59%	277 +47%	322 +16%	717 +123%	773 +8%	1 016 +31%	1 341 +32%	1 528 +14%	2 401 +57%	2 766 +15%	2 809 +2%	2 968 +6%	3 122 +5%	4 106 +32%	4 271 +4%	4 603 +8%	4 952 +8%	5 658 +14%	6 087 +8%
Total Liabilities & Equity	111 N/A	256 +132%	233 -9%	195 -16%	463 +137%	815 +76%	907 +11%	917 +1%	1 263 +38%	1 306 +3%	1 568 +20%	2 244 +43%	2 475 +10%	3 729 +51%	4 024 +8%	4 633 +15%	4 427 -4%	4 690 +6%	5 848 +25%	6 003 +3%	6 375 +6%	6 842 +7%	6 989 +2%	7 594 +9%
Shares Outstanding
Common Shares Outstanding	54	64	65	74	97	97	100	101	111	115	126	144	149	162	173	176	178	180	182	184	186	189	191	192

Income Statement Balance Sheet Cash Flow Statement

Biomarin Pharmaceutical Inc
NASDAQ:BMRN

Balance Sheet

Balance Sheet Decomposition
Biomarin Pharmaceutical Inc

Balance Sheet
Biomarin Pharmaceutical Inc

See Also

Company

Help

Tools

Stocks

Biomarin Pharmaceutical Inc NASDAQ:BMRN

Balance Sheet

Balance Sheet Decomposition Biomarin Pharmaceutical Inc

Balance Sheet Biomarin Pharmaceutical Inc

See Also

Company

Help

Tools

Stocks

Biomarin Pharmaceutical Inc
NASDAQ:BMRN

Balance Sheet Decomposition
Biomarin Pharmaceutical Inc

Balance Sheet
Biomarin Pharmaceutical Inc